German pharma giant Bayer is set to cut 12,000 jobs by 2025 as part of a plan to focus on its core life sciences business.
The layoffs, which will affect 10% of Bayer’s 118,000 strong workforce, will be focused on corporate functions in Germany with 6,000 corporate functions jobs to be cut. However 4,100 crop sciences roles will be taken down following the $63 billion deal with Monsanto in which Bayer took on the role of the world’s largest agrochemicals company.
